Scenes from the Sickle Cell Foundation of Palm Beach County’s 2025 Eva Mack Breakfast at the Kravis Center on Saturday, April ...

“Our results reinforce that hydroxyurea, the most efficacious medicine available for sickle cell disease, continues to have ...

Bhopal: Governor Mangubhai Patel inaugurated the genetic analysis laboratory and DNA sequencer machine at BMHRC's sickle cell anaemia competence centre. He also launched a seminar titled "Genetic ...

Bengaluru: Scientists at Raman Research Institute (RRI), Bengaluru, created an affordable, portable device for preliminary screening of Sickle Cell Disease (SCD). Led by Prof Gautam Soni ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus immune checkpoint inhibitors. The first patient with small cell lung cancer ...

Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the ...

The quality of life of patients with sickle cell anemia is severely compromised similar to or even worse than patients with other chronic diseases such as arthritis. Patients who responded to ...

In a world where certain health conditions dominate headlines and funding priorities, sickle cell disease — a genetic blood ...

HealthDay News — For adults with sickle cell disease (SCD), C-reactive protein (CRP) levels increase significantly during the follicular phase of the menstrual cycle, according to a study published ...